Niemann-Pick Type C (NPC) is a rare genetic pediatric neurodegenerative disorder that affects cholesterol metabolism, leading to severe neurological symptoms and a life expectancy of less than 20 years. The disease is inherited in an autosomal recessive manner and has no known cure, with supportive therapies available to manage symptoms. Currently, there are limited cases diagnosed worldwide, highlighting the urgent need for awareness and research funding.